These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 32106380)

  • 1. Suppression of Fpr2 expression protects against endotoxin-induced acute lung injury by interacting with Nrf2-regulated TAK1 activation.
    Liu H; Lin Z; Ma Y
    Biomed Pharmacother; 2020 May; 125():109943. PubMed ID: 32106380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways.
    Qiu YL; Cheng XN; Bai F; Fang LY; Hu HZ; Sun DQ
    Biomed Pharmacother; 2018 Oct; 106():192-199. PubMed ID: 29958143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling.
    Pei X; Zhang XJ; Chen HM
    Biochem Biophys Res Commun; 2019 Aug; 516(1):270-277. PubMed ID: 31248593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
    Yang H; Lv H; Li H; Ci X; Peng L
    Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway.
    Lu Y; Yu T; Liu J; Gu L
    PLoS One; 2018; 13(4):e0196405. PubMed ID: 29694408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of tripartite motif 8 protects against lipopolysaccharide (LPS)-induced acute lung injury by regulating AMPKα activity.
    Xiaoli L; Wujun Z; Jing L
    Biochem Biophys Res Commun; 2019 Jan; 508(3):701-708. PubMed ID: 30527811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orientin relieves lipopolysaccharide-induced acute lung injury in mice: The involvement of its anti-inflammatory and anti-oxidant properties.
    Xiao Q; Cui Y; Zhao Y; Liu L; Wang H; Yang L
    Int Immunopharmacol; 2021 Jan; 90():107189. PubMed ID: 33214095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
    Mo M; Li S; Dong Z; Li C; Sun Y; Li A; Zhao Z
    Int Immunopharmacol; 2020 Apr; 81():106273. PubMed ID: 32070920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echinatin attenuates acute lung injury and inflammatory responses via TAK1-MAPK/NF-κB and Keap1-Nrf2-HO-1 signaling pathways in macrophages.
    Luo L; Wang H; Xiong J; Chen X; Shen X; Zhang H
    PLoS One; 2024; 19(5):e0303556. PubMed ID: 38753858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRBN knockdown mitigates lipopolysaccharide-induced acute lung injury by suppression of oxidative stress and endoplasmic reticulum (ER) stress associated NF-κB signaling.
    Yang H; Song Z; Hong D
    Biomed Pharmacother; 2020 Mar; 123():109761. PubMed ID: 31865141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hucMSC Conditioned Medium Ameliorate Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Oxidative Stress and Inflammation via Nrf2/NF-
    Tang Y; Ding F; Wu C; Liu B
    Anal Cell Pathol (Amst); 2021; 2021():6653681. PubMed ID: 34426780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
    Huang Y; Huang L; Zhu G; Pei Z; Zhang W
    J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state.
    Jiang W; Luo F; Lu Q; Liu J; Li P; Wang X; Fu Y; Hao K; Yan T; Ding X
    Chem Biol Interact; 2016 Jan; 243():127-34. PubMed ID: 26363199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalin ameliorates lipopolysaccharide-induced acute lung injury in mice by suppressing oxidative stress and inflammation via the activation of the Nrf2-mediated HO-1 signaling pathway.
    Meng X; Hu L; Li W
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1421-1433. PubMed ID: 31273392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of endotoxin-induced acute lung injury in rats by bone marrow-derived mesenchymal stem cells: Role of Nrf2/HO-1 signal axis in inhibition of NLRP3 activation.
    Lei L; Guo Y; Lin J; Lin X; He S; Qin Z; Lin Q
    Biochem Biophys Res Commun; 2021 Apr; 551():7-13. PubMed ID: 33713981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chicoric acid alleviates lipopolysaccharide-induced acute lung injury in mice through anti-inflammatory and anti-oxidant activities.
    Ding H; Ci X; Cheng H; Yu Q; Li D
    Int Immunopharmacol; 2019 Jan; 66():169-176. PubMed ID: 30466029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF1 meditates lipopolysaccharide-induced acute lung injury by up regulating JNK activation.
    Bin W; Ming X; Wen-Xia C
    Biochem Biophys Res Commun; 2019 Mar; 511(1):49-56. PubMed ID: 30760405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bakuchiol regulates TLR4/MyD88/NF-κB and Keap1/Nrf2/HO-1 pathways to protect against LPS-induced acute lung injury in vitro and in vivo.
    Zhao L; Zhang Z; Li P; Gao Y; Shi Y
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3301-3312. PubMed ID: 37930390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-18 binding protein attenuates lipopolysaccharide-induced acute lung injury in mice via suppression NF-κB and activation Nrf2 pathway.
    Zhang LM; Zhang J; Zhang Y; Wang L; Fei C; Yi ZW; Dong L
    Biochem Biophys Res Commun; 2018 Nov; 505(3):837-842. PubMed ID: 30301527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.
    Lv H; Yu Z; Zheng Y; Wang L; Qin X; Cheng G; Ci X
    Int J Biol Sci; 2016; 12(1):72-86. PubMed ID: 26722219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.